Use of arachidonic acid to reduce the risk of insulin resistance later in life

摘要

Use of arachidonic acid in the preparation of a nutritional composition for administration to a child during the first 3 years of life, preferably during the first 12 months of life, in order to reduce the risk of developing insulin resistance in his life later, so that * said nutritional composition is a infant formula or a continuation formula, and * said nutritional composition comprises a protein source, a lipid source and a carbohydrate source, and * the lipid source contains arachidonic acid , and * said nutritional composition has a protein content of less than 1.85 g / 100kcal and * said nutritional composition does not contain docosahexanoic acid (DHA), and the amount of arachidonic acid contained in the lipid source of the composition being administered This child is 5 mg to 100 mg daily per kg.